How large is the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market, and what is its growth trajectory?
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size has grown strongly in recent years. It will grow from $1.83 $ billion in 2024 to $1.95 $ billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to the increasing prevalence of cardiovascular diseases, the aging population, the growing preference for minimally invasive procedures, rising obesity rates, and improved healthcare infrastructure.
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market size is expected to see strong growth in the next few years. It will grow to $2.52 $ billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to increased emphasis on preventive healthcare, patient preference for shorter hospital stays, favorable reimbursement policies, increasing adoption of drug-eluting balloons, and improved diagnostic techniques. Major trends in the forecast period include technological advancements, expansion into emerging markets, increased patient awareness, customized catheters, and integration with imaging technologies.
Get Your Free Sample of The Global Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19641&type=smp
What are the key forces behind the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market’s growth in recent years?
The increase in cardiovascular diseases is expected to propel the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market going forward. Cardiovascular diseases are rising due to lifestyle factors such as poor diet, lack of exercise, and increased stress, along with an aging global population. Percutaneous transluminal coronary angioplasty dilation catheters are used in cardiovascular diseases to open narrowed or blocked coronary arteries, restoring blood flow to the heart. For instance, in June 2024, the American Heart Association, a US-based public health organization that supports cardiovascular medical research, reported that 45 million adults in the USA are expected to have some form of cardiovascular disease by 2050, up from 28 million in 2020. This projection includes significant increases in hypertension, expected to rise from 51.2% to 61.0%, and obesity, projected to grow from 43.1% to 60.6%. Therefore, the increase in cardiovascular diseases is driving the growth of the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market.
What are the major segments of the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market?
The percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market covered in this report is segmented –
1) By Type: Semi-Compliant Type, Non-Compliant Type
2) By Material Type: Polyurethane, Nylon, Other Material Types
3) By Application: Hospitals, Medical Research Institute, Other Applications
Subsegments:
1) By Semi-Compliant Type: Standard Semi-Compliant Catheters, Specialized Semi-Compliant Catheters
2) By Non-Compliant Type: Standard Non-Compliant Catheters, High-Pressure Non-Compliant Catheters
Order your report now for swift delivery
Which companies dominate the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market?
Major companies operating in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are Cardinal Health Inc., Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co Ltd., Merit Medical Systems Inc., Cordis Corporation, MicroPort Scientific Corporation, Biosensors International Group Ltd., Alvimedica Medical Technologies, BrosMed Medical Co Ltd., iVascular SLU, Hexacath, Translumina Therapeutics LLP, Eurocor Tech GmbH, GADA S.p.A., Invamed Group
What major trends will shape the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market during the forecast period?
Major companies in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market are focusing on developing advanced products such as dilation catheters with twin-wall technology to enhance balloon strength and effective artery dilation. Dilation catheters with twin-wall technology are medical devices designed to perform precise and controlled dilation procedures. They feature a unique construction with two concentric layers, or walls, that enhance the catheter’s strength, flexibility, and durability. For instance, in February 2023, SIS Medical AG, a Switzerland-based medical device company, launched the OPN NC percutaneous transluminal coronary angioplasty (PTCA) dilatation catheter with Twin-Wall technology in the USA. This catheter offers super high-pressure resistance with a rated burst pressure of 35 atm and low compliance, making it suitable for post-dilatation of under-expanded stents. This unique design provides exceptional pressure resistance and very low compliance, enabling effective treatment of challenging coronary lesions without the risk of over-dilation.
What are the key regional dynamics of the percutaneous transluminal coronary angioplasty (ptca) dilation catheters market, and which region leads in market share?
North America was the largest region in the percutaneous transluminal coronary angioplasty dilation catheters market in 2024. The regions covered in the percutaneous transluminal coronary angioplasty (PTCA) dilation catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Percutaneous Transluminal Coronary Angioplasty (PTCA) Dilation Catheters Market Report 2025 Offer?
The percutaneous transluminal coronary angioplasty (ptca) dilation catheters market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Percutaneous transluminal coronary angioplasty (PTCA) dilation catheters are medical devices used to open narrowed or blocked coronary arteries. They involve inserting a catheter with a small balloon at its tip into the artery, then inflating the balloon to widen the artery and improve blood flow. This minimally invasive procedure helps restore proper circulation to the heart.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19641
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
